XML 50 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues:                      
Revenues $ 17,646 $ 15,173 $ 7,556 $ 1,920         $ 42,295 $ 6,019 $ 28,795
Operating expenses:                      
Cost of products sold $ 2,033 $ 1,744 $ 822 $ 138         $ 4,737 $ 0 $ 0
Cost, product and service, extensible enumeration FOTIVDA U.S. product revenue, net FOTIVDA U.S. product revenue, net FOTIVDA U.S. product revenue, net FOTIVDA U.S. product revenue, net         FOTIVDA U.S. product revenue, net FOTIVDA U.S. product revenue, net FOTIVDA U.S. product revenue, net
Research and development $ 6,121 $ 7,502 $ 6,878 $ 5,797 $ 4,574 $ 5,860 $ 4,419 $ 7,826 $ 26,298 $ 22,679 $ 17,958
Selling, general and administrative 15,652 15,142 14,920 15,100 9,008 5,800 3,737 3,672 60,814 22,217 11,211
Operating expenses 23,806 24,388 22,620 21,035 13,582 11,660 8,156 11,498 91,849 44,896 29,169
Loss from operations (6,160) (9,215) (15,064) (19,115) (12,696) (8,060) (7,407) (10,714) (49,554) (38,877) (374)
Other income (expense), net:                      
Interest expense, net (1,153) (1,153) (1,128) (611) (522) (419) (349) (315) (4,045) (1,605) (1,815)
Change in fair value of PIPE Warrant liability 0 0 2,595 (2,396) 1,714 86 450 2,648 199 4,898 11,577
Other income 58 0 0 0         58 0 0
Other income (expense), net (1,095) (1,153) 1,467 (3,007) 1,192 (333) 101 2,333 (3,788) 3,293 9,762
Net income (loss) $ (7,255) $ (10,368) $ (13,597) $ (22,122) $ (11,504) $ (8,393) $ (7,306) $ (8,381) $ (53,342) $ (35,584) $ 9,388
Basic net income (loss) per share                      
Net income (loss) per share (in dollars per share) $ (0.21) $ (0.30) $ (0.40) $ (0.81) $ (0.44) $ (0.33) $ (0.42) $ (0.52) $ (1.63) $ (1.66) $ 0.61
Weighted average number of common shares outstanding (in shares) 34,384,000 34,374,000 34,362,000 27,429,000 26,252,000 25,808,000 17,364,000 16,081,000 32,661,000 21,402,000 15,331,000
Diluted net income (loss) per share                      
Net income (loss) per share (in dollars per share) $ (0.21) $ (0.30) $ (0.40) $ (0.81) $ (0.44) $ (0.33) $ (0.42) $ (0.52) $ (1.63) $ (1.66) $ 0.61
Weighted average number of common shares outstanding (in shares) 34,384,000 34,374,000 34,362,000 27,429,000 26,252,000 25,808,000 17,364,000 16,081,000 32,661,000 21,402,000 15,376,000
FOTIVDA U.S. product revenue, net                      
Revenues:                      
Revenues $ 16,755 $ 14,318 $ 6,735 $ 1,066         $ 38,874 $ 0 $ 0
Partnership licensing and royalty revenue                      
Revenues:                      
Revenues $ 891 $ 855 $ 821 $ 854 $ 886 $ 3,600 $ 749 $ 784 $ 3,421 $ 6,019 $ 28,795